✦ LIBER ✦

A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer

✍ Scribed by Joan Carles Galcerán; Romà Bastus Piulats; Javier Martín-Broto; Pablo Maroto Rey; Miquel Nogué Aligué; Montserrat Domenech Santasusana; Angels Arcusa Lanza; Joaquim Bellmunt Molins; Catherine Colin; Atika Girard

Book ID: 110645970
Publisher: Springer Milan
Year: 2005
Tongue: Spanish
Weight: 148 KB
Volume: 7
Category: Article
ISSN: 1699-048X
DOI: 10.1007/bf02710012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vinorelbine and estramustine in androgen

Vinorelbine and estramustine in androgen-independent metastatic prostate cancer : A Phase II study

✍ Matthew R. Smith; Donald Kaufman; William Oh; Kimberly Guerin; Michael Seiden; T 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

A phase II trial of docetaxel and vinore

A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer

✍ Susan Goodin; Kamakshi V. Rao; Michael Kane; Nisha Dave; Terry Capanna; Susan Do 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

Oral estramustine and cyclophosphamide i

Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma : A phase II study

✍ Sergio Bracarda; Maurizio Tonato; Paolo Rosi; Verena De Angelis; Ettore Mearini; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## BACKGROUND. Nearly all cases of metastatic prostate carcinoma progress, after hormonal ablation, to a hormone refractory status. To the authors' knowledge no standard chemotherapy for patients with hormone refractory prostate carcinoma (HRPC) exists. In a prospective study, the efficacy and toxi

Long-term outcome of a phase II study of

Long-term outcome of a phase II study of weekly docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patients

✍ A. González-Martín; E. Fernández; M. A. Vaz; J. Burgos; M. López García; R. Rodr 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 92 KB

Phase II clinical study of pirarubicin i

Phase II clinical study of pirarubicin in hormone resistant prostate cancer

✍ Bernardo Leon Rapoport; Geoffrey Falkson 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 178 KB

Phase II study of sequential chemotherap

Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer

✍ Galli, L; Fontana, A; Galli, C; Landi, L; Fontana, E; Antonuzzo, A; Andreuccetti 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB